Cedars-Sinai led clinical trial that showed treatment reduced deaths in patients with an aggressive form of the disease.
India's path towards strong crypto compliance is strategic and symbolic. It signals the country's determination to be a ...
While Natera said it will seek FDA approval for Signatera based on data from IMvigor011, the readout from another ctDNA-guided de-escalation study was more nuanced.